// App-Quantinova.ai

363 2016 ATVB : Thrombin Activatable Fibrinolysis Inhibitor is a Regulator of Angiogenic Potential in Endothelial Cells

Researchers

Presenter

  • Jennifer L Balun

Principal Investigators

  • Michael B Boffa

Medical Centers

  • University of Windsor, Windsor, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Coronary Artery Disease

  • Solid malignancies

Biomarkers

  • Matrix metalloproteinase

  • Thrombin-activatable fibrinolysis inhibitor

Drug/Treatment

  • Thrombomodulin alfa

  • Protein C

  • Arginine hydrochloride

  • Evithrom

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved